Stricter rules on smoking, reimbursed anti-smoking programmes and smoke-free public places are among the ways to prevent chronic obstructive pulmonary disease (COPD) from being a public health crisis, says Mikaela Odemyr.
Organisations of patients with rare diseases have warned EU policymakers to “think carefully” before reviewing the incentives in the orphan drugs regulation, claiming that the pharma industry should not be discouraged from investing in new therapies.
As long as the political will exists, a coalition of EU member states can speed up the healthcare data mobility in Europe and start showing results in a cross-border manner in order for others to join, an Estonian government official told EURACTIV.
“Salami-slicing” the cost of medicines, which represent almost one-fifth of health system budgets and are subject to rigorous value assessments, won’t make healthcare systems more sustainable in the future, Nathalie Moll told EURACTIV.com in an interview.
Efforts to digitalise healthcare for chronic disease patients – including those suffering from diabetes – are helpful, according to the European Public Health Alliance (EPHA). But the move towards digitalisation should not exacerbate existing health inequalities, it warns.
The Maltese EU presidency will seek more transparency in the way pharmaceutical companies negotiate with member states on medicines’ pricing, Health Minister Chris Fearne said in an interview with EURACTIV.
One in seven people with HIV in Europe is unaware of their infection, the EU and World Health Organization reported Tuesday (29 November) as 2015 marked another record year for new HIV cases in the region.
The European Commission is determined to further strengthen its antimicrobial resistance action for the period beyond 2016, an EU official has told EURACTIV.com, dismissing allegations that the EU executive lacks the political will to do so.
The UK's vote to leave the European Union has come at a crucial moment in the development of an international medical project that throws into sharp relief the state of flux Brexit has cast over collaborative research, says Jack Barton.
A new breed of drugs, called “value added medicines”, could help patients improve their everyday life while in treatment, without increasing healthcare budgets, Christoph Stoller said in an interview with EURACTIV.com
SPECIAL REPORT / People who are well-versed in health issues make better lifestyle choices, avoid developing chronic diseases and lead longer lives. But with health literacy varying greatly across the EU, campaigners are calling for action from politicians.
As the EU moves forward on the joint action and other initiatives to promote health literacy, healthy lifestyles and the prevention of diseases, oral health should not be forgotten, say Karin Kadenbach and Kenneth Eaton.